Najmeh Ahangari Selected Research

Najmeh Ahangari Research Topics

2	Dyslipidemias (Dyslipidemia) 10/2021 - 01/2021
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 12/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023
1	Myotonia Congenita (Thomsen Disease) 12/2022
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 10/2019
1	Infections 09/2019
1	Wounds and Injuries (Trauma) 03/2019
1	Niemann-Pick Diseases (Niemann Pick Disease) 01/2019
1	Cataract (Cataracts) 11/2018
1	Sensorineural Hearing Loss 11/2018
1	Infantile Spasms (West Syndrome) 11/2018
1	Hypercholesterolemia 01/2018
1	Microcephaly 01/2018
1	Neoplasms (Cancer) 01/2018
1	Autosomal Recessive 28 Deafness 01/2018
1	Autosomal Recessive 21 Deafness 05/2016

2	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2018
2	CholesterolIBA 10/2021 - 01/2019
2	CopperIBA 10/2021 - 09/2019
2	ZincIBA 10/2021 - 09/2019
2	Apolipoproteins B (ApoB)IBA 01/2021 - 01/2018
2	CurcuminIBA 10/2019 - 03/2019
2	polyacrylamideIBA 01/2018 - 05/2016
1	Chloride Channels (Chloride Channel)IBA 12/2022
1	Adenosine Triphosphate (ATP)IBA 10/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	Lipoproteins (Lipoprotein)IBA 01/2021
1	MicroRNAs (MicroRNA)IBA 12/2019
1	Cyclin D1IBA 10/2019
1	Sorafenib (BAY 43-9006)FDA Link 10/2019
1	LipidsIBA 01/2019
1	neodymium pyrocatechin disulfonate (NPD)IBA 01/2019
1	Growth Hormone (Somatotropin)IBA 11/2018
1	Bile Acids and Salts (Bile Acids)IBA 01/2018
1	PCSK9 InhibitorsIBA 01/2018
1	Ezetimibe (Zetia)FDA Link 01/2018
1	KinesinsIBA 01/2018
1	serum P-component (CIt)IBA 01/2018
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018
1	citron-kinaseIBA 01/2018

1	Therapeutics 01/2018